Suppression of high mobility group box 1 in B16F10 tumor does not inhibit the induction of neoantigen-specific T cells.

Waki, Kayoko; Ozawa, Miyako; Yamada, Akira

Waki, Kayoko; Ozawa, Miyako; Yamada, Akira.

Afiliação

Waki K; Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, Japan.
Ozawa M; Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, Japan.
Yamada A; Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, Japan.

Cancer Sci ; 113(12): 4082-4091, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36057084

Assuntos

Neoplasias; Linfócitos T; Animais; Camundongos; Imunidade Adaptativa; Antígenos de Neoplasias/genética; Imunoterapia; Microambiente Tumoral

Palavras-chave

HMGB1; alarmin; cytotoxic T-lymphocytes; neoantigen; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google